Merck logo

Director, Global Oncology Market Access, Alliances (New Products)

Merck

Rahway, NJ; North Wales, PAHybridPosted 2 days ago$190,800.00 - $300,300.00
Full TimeDirector & AboveCommercial & Pharma SalesPharmaceutical
Original posting ↗

Summary

The Director, Oncology Global Market Access – Alliances reports to the Executive Director, Alliances and leads global market access strategy for oncology pipeline assets across multiple indications within alliance settings. This role supports high-priority oncology alliance assets representing multi-billion-dollar commercial opportunities and the potential to improve outcomes for patients globally.

Job description

The role is responsible for shaping clear, actionable market access and pricing recommendations by integrating strategic, clinical development, commercial, and forecasting considerations. The individual in this position will translate complex market dynamics and cross-functional input into concise, decision-ready insights for senior leaders and alliance governance bodies.

Primary Responsibilities

  • Lead global market access and pricing strategy across assigned oncology assets and indications in alliance environments
  • Develop clear, decision-ready recommendations that connect access, pricing, clinical, and commercial implications
  • Lead asset-level price strategy and support internal price forecasting in alignment with broader access strategy, business priorities, and relevant agreement parameters
  • Partner with commercial, tumor access, CORE, V&I, pricing, and alliance teams to support strategic planning and execution
  • Provide market access input into evidence and development planning, including implications for value strategy, launch planning, indication expansion, future access needs, and pricing considerations
  • Engage regional and local market access teams, including the U.S., to ensure strategies reflect key market realities while maintaining a global perspective
  • Synthesize detailed data, stakeholder input, and market complexity into clear summaries and recommendations for senior leaders and governance forums
  • Contribute to Global Plan for Access materials, value implementation planning, access summaries, internal pricing discussions, and forecast-related strategic input
  • Monitor the external environment, including payer trends, competitor activity, pricing dynamics, and emerging access implications, to inform strategic choices
  • Support cross-functional planning by linking market access and pricing implications to broader business priorities and decision points

Qualifications Required

  • BA/BS in Business, Science, or a related field
  • Minimum of 5 years of relevant experience in market access, pricing, reimbursement, commercial strategy, consulting, or related areas
  • Strong understanding of oncology, product development, commercialization, and pricing considerations
  • Experience working with or strong familiarity with the U.S. market, combined with broader global market access exposure
  • Demonstrated ability to translate complex analysis into clear strategic recommendations
  • Strong commercial orientation and business acumen
  • Excellent verbal and written communication skills, including the ability to distill complexity into a concise, compelling story
  • Experience leading complex cross-functional initiatives in a matrix environment
  • Strong stakeholder management, collaboration, and influence skills
  • Strategic thinking and sound judgment in ambiguous or evolving situations

Preferred

  • Advanced degree such as MBA, MS, or other relevant postgraduate degree
  • Experience in alliance settings or highly matrixed cross-company environments
  • Consulting experience
  • Deep oncology and market access experience
  • Experience supporting pricing strategy and forecast-related discussions

Requirements

  • BA/BS in Business, Science, or a related field
  • Minimum of 5 years of relevant experience in market access, pricing, reimbursement, commercial strategy, consulting, or related areas
  • Strong understanding of oncology, product development, commercialization, and pricing considerations
  • Experience working with or strong familiarity with the U.S. market, combined with broader global market access exposure
  • Demonstrated ability to translate complex analysis into clear strategic recommendations
  • Strong commercial orientation and business acumen
  • Excellent verbal and written communication skills
  • Experience leading complex cross-functional initiatives in a matrix environment
  • Strong stakeholder management, collaboration, and influence skills
  • Strategic thinking and sound judgment in ambiguous or evolving situations
  • Data Analysis
  • Health Economics Research
  • Market Access
  • Market Research
  • Oncology
  • Oncology Marketing
  • Pricing Strategies
  • Strategic Thinking

Benefits

  • Medical, Dental & Vision
  • 401(k) Matching
  • Retirement Benefits
  • Paid Holidays
  • Vacation
  • Compassionate & Sick Days
  • Annual Bonus
  • Long-Term Incentive

Company overview

Merck & Co., Inc., known as Merck in the United States and Canada and MSD (Merck Sharp & Dohme) internationally, is a premier American multinational pharmaceutical company headquartered in Rahway, New Jersey. Founded in 1891 as the U.S. subsidiary of the German Merck Group, the company became independent following World War I and has since grown into one of the world's largest biomedical companies, ranking fourth globally by revenue. Merck operates across three core business segments: pharmaceuticals, vaccines, and animal health products. The company is renowned for its groundbreaking research and development, having brought numerous life-saving medicines to market including Keytruda (pembrolizumab), a leading immunotherapy for cancer treatment that generated $29.5 billion in 2024 revenue, and Gardasil, a revolutionary HPV vaccine. With approximately 75,000 employees worldwide, Merck maintains a robust pipeline of innovative therapies focused on oncology, vaccines, hospital acute care, cardiology, neuroscience, virology, immunology, and diabetes. The company invests heavily in R&D, spending $17.9 billion in 2024 alone, demonstrating its commitment to advancing scientific discovery. Merck's legacy spans over 130 years of bringing hope to humanity through important medicines and vaccines, operating with a purpose to use leading-edge science to save and improve lives globally while fostering an inclusive workforce and responsible business practices.

Explore more jobs of your matchFind more biopharma roles with GetBioJob.